Gavreto 50242-0210
Generic: Pralsetinib
Product NDC
50242-0210- Manufacturer
- Genentech, Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 1, 2021
- Application
- NDA213721
Need to source Gavreto? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pralsetinib | 100 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Kinase Inhibitor [EPC]Rearranged during Transfection (RET) Inhibitors [MoA]
Packaging Options(3)
1 BOTTLE in 1 CARTON (50242-210-60) / 60 CAPSULE in 1 BOTTLE
1 BOTTLE in 1 CARTON (50242-210-83) / 60 CAPSULE in 1 BOTTLE
1 BOTTLE in 1 CARTON (50242-210-90) / 90 CAPSULE in 1 BOTTLE